Reuters: Deals: Sanofi to buy U.S. medical device firm Pluromed

Reuters: Deals Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Sanofi to buy U.S. medical device firm Pluromed Mar 16th 2012, 06:31 PARIS | Fri Mar 16, 2012 2:31am EDT PARIS (Reuters) - French drugmaker Sanofi has agreed to buy U.S. medical device company Pluromed to expand its presence in biosurgery, it said in a statement on Friday. Sanofi said it planned to commercialize Pluromed's LeGoo, a gel for temporarily controlling bleeding during surgical procedures. It did not give financial details of the transaction. "The acquisition of Pluromed underscores Sanofi's commitment to strengthen its biosurgery portfolio," said Alison Lawton, senior vice president and general manager at Sanofi Biosurgery. "LeGoo is a breakthrough technology with the potential to change the paradigm of vascular and cardiovascular surgical procedures, by providing fast, temporary control of blood flow while avoiding vessel trauma associated with standard of care."

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions